# Greenwich LifesciencesInc Current Ratio vs. Cash per Share

GLSI | Stock | ## USD 13.90 0.20 1.42% |

Greenwich |

Is Greenwich LifesciencesInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich LifesciencesInc. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich LifesciencesInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Market Capitalization 172.6 M | Return On Assets (0.21) | Return On Equity (0.34) |

The market value of Greenwich LifesciencesInc is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich LifesciencesInc's value that differs from its market value or its book value, called intrinsic value, which is Greenwich LifesciencesInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich LifesciencesInc's market value can be influenced by many factors that don't directly affect Greenwich LifesciencesInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Greenwich LifesciencesInc's value and its price as these two are different measures arrived at by different means. Investors typically determine Greenwich LifesciencesInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich LifesciencesInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

## Greenwich LifesciencesInc Cash per Share vs. Current Ratio Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Greenwich LifesciencesInc's current stock value. Our valuation model uses many indicators to compare Greenwich LifesciencesInc value to that of its competitors to determine the firm's financial worth. Greenwich LifesciencesInc is one of the top stocks in current ratio category among related companies. It is rated**# 2**in cash per share category among related companies fabricating about 0.02 of Cash per Share per Current Ratio. The ratio of Current Ratio to Cash per Share for Greenwich LifesciencesInc is roughly 53.89 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Greenwich LifesciencesInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Greenwich LifesciencesInc's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Greenwich LifesciencesInc's earnings, one of the primary drivers of an investment's value.

## Greenwich Cash per Share vs. Current Ratio

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Greenwich LifesciencesInc |
| = | 65.74 X |

Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).

Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Greenwich LifesciencesInc |
| = | 1.22 X |

Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

## Greenwich Cash per Share Comparison

Greenwich LifesciencesInc is currently under evaluation in cash per share category among related companies.

## Greenwich LifesciencesInc Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Greenwich LifesciencesInc, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Greenwich LifesciencesInc will eventually generate negative long term returns. The profitability progress is the general direction of Greenwich LifesciencesInc's change in net profit over the period of time. It can combine multiple indicators of Greenwich LifesciencesInc, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2neu-expressing cancers. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas. Greenwich Lifesciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

## Greenwich Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Greenwich LifesciencesInc. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Greenwich LifesciencesInc position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Greenwich LifesciencesInc's important profitability drivers and their relationship over time.

## Use Greenwich LifesciencesInc in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Greenwich LifesciencesInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greenwich LifesciencesInc will appreciate offsetting losses from the drop in the long position's value.## Greenwich LifesciencesInc Pair Trading

### Greenwich LifesciencesInc Pair Trading Analysis

The ability to find closely correlated positions to Greenwich LifesciencesInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Greenwich LifesciencesInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Greenwich LifesciencesInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Greenwich LifesciencesInc to buy it.

The correlation of Greenwich LifesciencesInc is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Greenwich LifesciencesInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Greenwich LifesciencesInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Greenwich LifesciencesInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.## Use Investing Themes to Complement your Greenwich LifesciencesInc position

In addition to having Greenwich LifesciencesInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.## Did You Try This Idea?

### Run Monster Funds Thematic Idea Now

##### Monster Funds

Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 36 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.

View All Next | Launch |

Please check Risk vs Return Analysis. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

## Complementary Tools for analysis

When running Greenwich LifesciencesInc price analysis, check to measure Greenwich LifesciencesInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich LifesciencesInc is operating at the current time. Most of Greenwich LifesciencesInc's value examination focuses on studying past and present price action to predict the probability of Greenwich LifesciencesInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich LifesciencesInc's price. Additionally, you may evaluate how the addition of Greenwich LifesciencesInc to your portfolios can decrease your overall portfolio volatility.

Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | Go | |

Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges | Go | |

Price TransformationUse Price Transformation models to analyze depth of different equity instruments across global markets | Go | |

Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios | Go | |

Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | Go |

To fully project Greenwich LifesciencesInc's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Greenwich LifesciencesInc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Greenwich LifesciencesInc's income statement, its balance sheet, and the statement of cash flows.